Benefits (Tables)

12 Months Ended

Jun. 27, 2020

Retirement Benefits [Abstract]

Schedule of Net Funded Status [Table Text Block]

U.S. Employees Postretirement Medical Expense & Funded Status Reconciliation

The Company provides postretirement medical expenses to certain former employees of Dallas Semiconductor and to certain Maxim Integrated executives. The Company adopted the postretirement medical plan as a result of the Company's acquisition of Dallas Semiconductor in 2001. A reconciliation of the funded status of these postretirement benefits, is as follows:

	June 27, 2020			Estimated Fiscal Year 2021 Expense		June 29, 2019			Fiscal Year 2020 Expense
	(in thousands, except percentages)
Accumulated postretirement benefit obligation:
Retirees and beneficiaries	$	(19,115	)			$	(18,241	)
Active participants	(1,413		)			(1,437		)
Funded status	$	(20,528	)			$	(19,678	)
Actuarial gain (loss)	$	705				$	118
Prior service cost	—					—
Amounts recognized in accumulated other comprehensive income:
Net actuarial loss	$	1,877				$	1,172
Prior service cost	249					606
Total	$	2,126				$	1,778
Net periodic postretirement benefit cost:
Interest cost				$	524				$	695
Amortization:
Prior service cost				249					356
Total net periodic postretirement benefit cost				$	773				$	1,051
Employer contributions				$	740				$	550
Economic assumptions:
Discount rate	2.6%					3.6%
Medical trend	7.00%-5.00%					7.25%-5.00%

Schedule of Expected Benefit Payments [Table Text Block]

The following benefit payments are expected to be paid:

	Non-Pension Benefits
Fiscal Year	(in thousands)
2021	$	739
2022	789
2023	817
2024	867
2025	916
Thereafter	16,400
Total	$	20,528